Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond

Multiomic analyses have shed light upon the molecular heterogeneity and complexity of triple-negative breast cancers (TNBCs). With increasing recognition that TNBC is not a single disease entity but encompasses different disease subtypes, a one-size-fits-all treatment paradigm has become obsolete. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Jack J., Tan, Tira J. Y., Dent, Rebecca A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
TNBC in 2019: Promising Signals for the Treatment of a Formidable Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785914/
https://www.ncbi.nlm.nih.gov/pubmed/31636720
http://dx.doi.org/10.1177/1758835919880429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6785914/
https://www.ncbi.nlm.nih.gov/pubmed/31636720
http://dx.doi.org/10.1177/1758835919880429

Ejemplares similares